NeutriSci International Inc V.NU.H

Alternate Symbol(s): NRXCF

NeutriSci International Inc. (NeutriSci) is a Canada-based company, which specializes in the production, and formulation of nutraceutical products within the business-to-business (B2B) industry. The Company is focused on the market development for its nutraceutical products. Its products utilize patented form of Pterostilbene called pTeroPure. pTeroPure Pterostilbene is a form of all-trans Pterostilbene that is found naturally in blueberries and is manufactured for NeutriSci by ChromaDex Corp. (ChromaDex) in the United States. NeutriSci’s neuenergy product is an energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash that is associated with energy products. It has developed proprietary IP and technology (NeutriSci IP) that creates an efficient method of bilingual absorption of nutraceuticals into the bloodstream. NeutriSci’s IP can be applied to many different categories in the beverage, food, and nutraceutical space.

TSXV:NU.H - Post by User

NeutriSci International Inc > Q1 on sedar

<< Previous

Bullboard Posts

Next >>

Comment by Edcandoon May 28, 2022 6:16pm

105 Views

Post# 34714842

RE:Q1 on sedar

One more point to add. I'm 99.9999% sure that the high cost of goods includes some (if not all) of the cost of goods for this last tranche . As per the explanation I was given for why the first tranche couldn't go on Q4. Whether it's Glen or next fins that confirms this (one way or the other ), I'd imagine most of our profit is in the last tranche.

<< Previous

Bullboard Posts

Next >>

Debt-free cannabis company set for next stage of growth